勁馬產(chǎn)品文獻(xiàn):人TGF-α,小鼠IL-2,ELISA試劑盒引用文獻(xiàn)

【資料簡(jiǎn)介】

【文獻(xiàn)標(biāo)題】Synthesis, characterization and biological safety of O-carboxymethyl chitosan used to treat Sarcoma 180 tumor

【作者】Meiling Zheng, Baoqin Han, Yan Yang,et.al

【作者單位】中國(guó)海洋大學(xué)（Ocean University of China）

【文獻(xiàn)中引用產(chǎn)品】

人轉(zhuǎn)化生長(zhǎng)因子α(TGF-α)ELISA試劑盒

人血管內(nèi)皮細(xì)胞生長(zhǎng)因子(VEGF)ELISA試劑盒

小鼠白細(xì)胞介素2(IL-2)ELISA試劑盒

小鼠腫瘤壞死因子α(TNF-α)ELISA試劑盒

【關(guān)鍵詞】Carboxymethyl chitosan,Sarcoma 180,Tumor,Biological safety,Biomaterial

【DOI】10.1016/j.carbpol.2011.04.038

【影響因子(IF)】4.2

【出版期刊】《Carbohydrate Polymers》

【產(chǎn)品原文引用】

2.1. Materials

Chitosan (degree of deacetylation = 78.0%) was supplied by Qingdao Biotemed Biomaterial Co., Ltd (China). RPMI 1640 media and Newborn calf serum (NCS) were obtained from GIBCO (USA). Human transforming growth factor-α(TGF-α) ELISA kit,

human vascular endothelial growth factor (VEGF) ELISA kit, mouse interleukin-2 (IL-2) ELISA kit and mouse tumor necrosis factor-α(TNF-α) ELISA kit were all procured from ShangHai JinMa Exper-imental Equipment Co., Ltd. (China).